Delcath Systems Inc. (NASDAQ: DCTH) Stock Information | RedChip

Delcath Systems Inc. (NASDAQ: DCTH)


$11.2800
-0.1600 ( -1.05% ) 50.4K

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Market Data


Open


$11.2800

Previous close


$11.4400

Volume


50.4K

Market cap


$360.50M

Day range


$11.1500 - $11.6700

52 week range


$3.7000 - $13.3011

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 92 Aug 05, 2024
8-k 8K-related 16 Jul 19, 2024
8-k 8K-related 13 Jul 09, 2024
8-k 8K-related 15 May 29, 2024
4 Insider transactions 1 May 28, 2024
4 Insider transactions 1 May 28, 2024
4 Insider transactions 1 May 28, 2024
4 Insider transactions 1 May 28, 2024
4 Insider transactions 1 May 28, 2024
3 Insider transactions 2 May 28, 2024

Latest News